Halki Diabetes Remedy

Diabetes Natural Treatment

Get Instant Access

1. Babkin B.P. 1949. Pavlov: a biography. Chicago: Chicago University Press.

2. Bayliss M. and Starling B.H. 1902. Mechanism of pancreatic secretion. J. Physiol. Lond. 28:325-353.

3. Mutt V., Magnusson S., Jorpes J.E., and Dahl E. 1965. Structure of porcine secretin. I. Degradation with trypsin and thrombin, sequence of the tryptic peptides with C-terminal residue. Biochemistry 4:2358-2362.

4. Jorpes E. and Mutt V. 1966. Cholecystokinin and pancreozymin, one single hormone? Acta Physiol. Scand. 66:196-202.

5. Green G.M. and Lyman R.L. 1972. Feedback regulation of pancreatic enzyme as a mechanism for trypsin inhibitor-induced hypersecretion in rats. Proc. Soc. Exp. Biol. Med. 140:6-12.

6. Chey W.Y., Lee Y.H., Hendricks J.F., Rhodes R.A., and Tai H.H. 1978. Plasma secretin concentration in fasting and postprandial in man. Am. J. Dig. Dis. 23:981-988.

7. Schaffalitzky de Muckadel O.B. and Fahrenkrug J. 1978. Secretion pattern of secretin in man. Regulation of gastric acid. Gut 19:812-828.

8. Kim M.S., Lee K.Y., and Chey W.Y. 1979. Plasma secretin concentrations in fasting and postprandial states in dog. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5):E539-E544.

9. Chey W.Y., Kim M.S., Lee K.Y., and Chang T.M. 1979. Effect of rabbit anti-secretin serum on postprandial pancreatic secretion in dog. Gastroenterology 77:1268-1275.

10. Hildenbrand P., Beglinger C., Gyr K., Jansen J.B.M.J., Rovati L., Zuercher M., Lamers C.B.H.W., Setnikar I., and Stalder G.A. 1990. Effect of a cholecystokinin receptor antagonist on intestinal phase of pancreatic biliary responses in man. J. Clin. Invest. 85:640-646.

11. Jo Y.H., Lee K.Y., Chang T.M., and Chey W.Y. 1991. Role of cholecystokinin in pancreatic bicarbonage secretion in dogs. Pancreas 6:197-201.

12. Eysselein V.E., Eberlein G.A., Hesse W.H., Singer M.V., Goebell H., and Reeve Jr. J.R. 1987. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J. Biol. Chem. 262:214-217.

13. Chang T.M., Thagesen H., Lee K.Y., Roth F.L., and Chey W.Y. 2000. Canine vagus nerve stores cholecystokinin-58 and -8 but releases only cholecystokinin-8 upon electrical vagal stimulation. Regul. Pept. 87:1-7.

14. Feurle G.E., Baca I., and Knauf W. 1982. Atropine depresses release of neurotensin and its effect on the exocrine pancreas. Regul. Pept. 4:75-82.

15. Nustede R., Schmidt W.E., Kohler H., Folsch U.R., and Schafmayer A. 1993. Role of neurotensin in the regulation of exocrine pancreatic secretion in dogs. Regul. Pept. 44:25-32.

16. Lee K.Y., Zhou L., Ren X.S., Chang T.M., and Chey W.Y. 1990. An important role of endogenous insulin on exocrine pancreatic secretion in rats. Am. J. Physiol. 258 (Gastrointest. Liver Physiol. 21):G268-G274.

17. Lee K.Y., Shiratori K., Chen Y.F., Chang T.M., and Chey W.Y. 1986. A hormonal mechanism for the interdigestive pancreatic secretion in dogs. Am. J. Physiol. 251:G759-G764.

18. Shiratori K., Lee K.Y., Chang T.M., Jo Y.H., Coy D.H., and Chey W.Y. 1988. Role of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. Am. J. Physiol. 255:G535-G541.

19. Jin H., Cai L., Lee K.Y., Chang T.M., Li P., Wagner D., and Chey W.Y. 1993. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 105:208-215.

20. Putman W.S., Liddle R.A., and Williams J.A. 1989. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am. J. Physiol. 256:G698-G703.

21. Demar A.R., Taylor I.L., and Fink A.S. 1991. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas. Pancreas 6:419-426.

22. Gershon M.D. 1981. The enteric nervous system. Ann. Rev. Neurosci. 4:227-272.

23. Li J.P., Chang T.M., and Chey W.Y. 2001. Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats. Am. J. Physiol. Gas-trointest. Liver Physiol. 280:G595-G602.

24. Li Y., Hao Y., Zhu J., and Owyang C. 2000. Serotonin released from intestinal enterochromaffin cells mediated luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 118:1197-1207.

25. You C.H., Rominger J.M., and Chey W.Y. 1982. Effects of atropine on the action and release of secretin in humans. Am. J. Physiol. 242:G608-G611.

26. Li P., Chang T.M., and Chey W.Y. 1995. Neuronal regulation of the release and action of secretin-releasing peptide and secretin. Am. J. Physiol. 269:G305-G312.

27. Li Y. and Owyang C. 1993. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J. Clin. Invest. 92:418-424.

28. Lee S.T., Lee K.Y., Li P., Coy D., Chang T.M., and Chey W.Y. 1998. PACAP stimulates pancreatic secretion via the release of secretin and cholecystokinin (CCK) in rats. Gastroenterology 114:490-497.

29. Miyasake K., Masuda M., Kanai S., Sato N., Kurosawa M., and Funakoshi A. 2002. Central Orexin-A stimulates pancreatic exocrine secretion via the vagus. Pancreas 25:400-404.

30. Li Y., Jiang Y.C., and Owyang C. 1998. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow. Am. J. Physiol. 275:G957-G963.

31. Cowles R.A., Segura B.J., and Mulholland M.W. 2001. Stimulation of rat pancreatic exocrine secretion by cocaine- and amphetamine-regulated transcript peptide. Regul. Pept. 99:61-68.

32. Kirchgessner A.L. and Gershon M.D. 1990. Innervation of the pancreas by neurons in the gut. J. Neurosci. 10:1626-1642.

33. Singer M.V., Solomon T.E., Wood J., and Grossman M.I. 1980. Latency of pancreatic enzyme response to intraduodenal stimulants. Am. J. Physiol. 238:G23-G29.

34. Zhu J.X., Zhu X.Y., Owyang C., and Li Y. 2001. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J. Physiol. Lond. 530:431-442.

35. Chey W.Y. 1993. Hormonal control of pancreatic exocrine secretion. In The pancreas: biology, pathobiology, and disease. Go V.L.W et al. Eds. 2nd ed. New York: Raven Press. pp. 403-424.

36. Iwai K., Fukuoka S., Fushiki T., Tsujikawa M., Hirose M., Tsunasawa S., and Sakiyama F. 1987. Purification of a trypsin-sensitive cholecystokinin-releasing peptide from pancreatic juice. J. Biol. Chem. 262:8956-8959.

37. Spannagel A.W., Green G.M., Guan D., Liddle R.A., Faull K., and Reeve Jr. J.R. 1996. Purification and characterization of luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc. Natl. Acad. Sci. USA 93:4415-4420.

38. Herzig K.H., Schon I., Tatemoto K., Ohe Y., Li Y., Folsch U.R., and Owyang C. 1996. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc. Natl. Acad. Sci. USA 93:7927-7932.

39. Chen Z.W., Agerberth B., Gell K., Anderson M., Mutt V., Ostenson C.G., Efendic S., Barros-Sderling J., Persson B., and Jornvall H. 1988. Isolation and characterization of porcine diazepam-binding inhibitor. A polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur. J. Biochem. 174:239-245.

40. Li Y., Hao Y., and Owyang C. 2000. Diazepambinding inhibitor mediate feedback regulation of pancreatic secretion and postprandial release of chole-cystokinin. J. Clin. Invest. 105:351-359.

41. Chang T.M., Lee K.Y., Chang C.H., Li P., Song Y., Roth F.L., and Chey W.Y. 1999. Purification of two secretin-releasing peptides structurally related to phospholipase A2 from canine pancreatic juice. Pancreas 19:401-405.

42. Li J.P., Chang T.M., Wagner D., and Chey W.Y. 2001. Pancreatic phospholipase A2 from the small intestine is a secretin-releasing factor in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 581:G526-G532.

43. Li Y. and Owyang C. 1996. Peptone stimulated CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons. J. Clin. Invest. 97:1463-1470.

44. Scarpelli D.G. 1989. Toxicology of the pancreas. Toxicol. Appl. Pharmacol. 101:543-554.

45. Apte M.V., Wilson J.S., McCaughan G.W., Korsten M.A., Haber P.S., Norton I.D., and Pirola R.C. 1995. Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J. Lab. Clin. Med. 125:634-640.

46. Haber P.S., Wilson J.S., Apte M.V., Korsten M.A., and Pirola R.C. 1994. Chronic ethanol consumption increases the fragility of rat pancreatic zymogen granules. Gut 35:1474-1478.

47. Wilson J.S., Apte M.V., Thomas M.C., Haber P.S., and Pirola R.C. 1992. The effects of ethanol, acetaldehyde and cholesteryl esters on pancreatic lysosomes. Gut 33:1099-1104.

48. Pfutzer R.H., Tadic S.D., Li H.S., Thompson B.S., Zhang J.Y., Ford M.E., Eagon P.K., and Witcomb D.C. 2002. Pancreatic cholesterol esterase, ES-10, and fatty acid ethyl ester synthase III gene expression are increased in the pancreas and liver but not in the brain or heart with long-term ethanol feeding in rats. Pancreas 25:101-106.

49. Haber P.S., Wilson J.S., Apte M.V., and Pirola R.C. 1993. Fatty acid ethyl esters increase rat pancreatic lysosomal fragility. J. Lab. Clin. Med. 121:759-764.

50. Saluja A.K., Lu L., Yamaguchi Y., Hofbauer B., Runzi M., Dawra R., Bhatia M., and Steer M.L. 1997. A cholecystokinin-releasing factor mediates ethanol-induced stimulation of rat pancreatic secretion. J. Clin. Invest. 99:506-512.

51. Schmidt D.N., Devaux M.A., Biedzinski T.M., and Sarles H. 1983. Cholinergic stimulation and inhibition of pancreatic secretion in alcohol-adapted dogs. Scand. J. Gastroenterol. 18:425-431.

52. Berger Z. and Feher E. 1997. Degeneration of intrapancreatic nerve fibers after chronic alcohol administration in mice. Int. J. Pancreatol. 21:165-171.

53. Hartwig W., Werner J., Ryschich E., Mayer H., Schmidt J., Gebhard M.M., Herfarth C., and Klar E. 2000. Cigarette smoke enhances ethanol-induced pancreatic injury. Pancreas 21:272-278.

54. Chowdhury P., Doi R., Tangoku A., and Rayford P.L. 1995. Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int. J. Pancreatol. 18:257-264.

55. Hamel E. and Morisset J. 1978. Effects of cocaine on rat pancreatic enzyme secretion and protein synthesis. Am. J. Dig. Dis. 23:264-268.

56. Linari G., Antonille L., Nencini P., and Nucerito V. 2001. Ethanol combined with cocaine inhibits amylase release in guinea pig pancreatic lobules. Pharmacol. Res. 44:41-45.

Was this article helpful?

0 0
Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment